Literature DB >> 22462412

What would 5-HT do? Regional diversity of 5-HT(1) receptor modulation of primary afferent neurotransmission.

Mark Connor1.   

Abstract

5-HT (serotonin) is a significant modulator of sensory input to the CNS, but the only analgesics that selectively target G-protein-coupled 5-HT receptors are highly specific for treatment of headache. Two recent papers in BJP shed light on this puzzling situation by showing that primary afferent neurotransmission to the superficial layers of the spinal and trigeminal dorsal is inhibited by different subtypes of the 5-HT(1) receptor - 5-HT(1B(and 1D) ) in the trigeminal dorsal horn and 5-HT(1A) in the spinal dorsal horn. The inputs being studied probably include nociceptive afferents, and the similarities of the methods employed in the two studies minimize the possibility that the different findings are an experimental artefact. Rather, the findings raise interesting questions about the possible anatomical or functional basis for the apparent regional selectivity of 5-HT(1) receptor actions, and whether these differences could be exploited for therapy. The results also emphasize the relative lack of information we have about the molecular details of the pro- or anti-nociceptive actions of 5-HT itself on primary afferent neurotransmission.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462412      PMCID: PMC3481042          DOI: 10.1111/j.1476-5381.2012.01963.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Descending control of pain.

Authors:  Mark J Millan
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

2.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  5-HT(1B) receptors inhibit glutamate release from primary afferent terminals in rat medullary dorsal horn neurons.

Authors:  I-S Choi; J-H Cho; C-H An; J-K Jung; Y-K Hur; J-K Choi; I-S Jang
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat.

Authors:  S M Garraway; S Hochman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

6.  Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.

Authors:  J D Classey; T Bartsch; P J Goadsby
Journal:  Brain Res       Date:  2010-09-09       Impact factor: 3.252

7.  Effects of sumatriptan on rat medullary dorsal horn neurons.

Authors:  E A Jennings; R M Ryan; M J Christie
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

8.  Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Tamara King; Frank Porreca
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

9.  Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan.

Authors:  Tetsuro Nikai; Allan I Basbaum; Andrew H Ahn
Journal:  Pain       Date:  2008-08-23       Impact factor: 6.961

10.  Long-lasting synaptic facilitation induced by serotonin in superficial dorsal horn neurones of the rat spinal cord.

Authors:  Y Hori; K Endo; T Takahashi
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

View more
  1 in total

Review 1.  Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.

Authors:  Greg Dussor
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.